We therefore tested the hypothesis that the CFAP410 VNTR within intron 1 of the most 5' transcriptional start site is a transcriptional regulatory domain and that tandem repeat variation could be associated with both differential gene expression of CFAP410 and risk for ALS. This evidence concerns the gene CFAP410 and amyotrophic lateral sclerosis.